Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 4, 2006, Pages 683-689

  Franceschi, Silvia ^a   Montella, Maurizio ^c   Polesel, Jerry ^d   La Vecchia, Carlo ^e   Crispo, Anna ^c   Dal Maso, Luigino ^d   Casarin, Pietro ^f   Izzo, Francesco ^c   Tommasi, Luigi G ^d   Chemin, Isabelle ^b   Trépo, Christian ^b   Crovatto, Marina ^f   Talamini, Renato ^d  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b Institut National de la Sante   (France)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f S MARIA DEGLI ANGELI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; TOBACCO;

ADULT; AGED; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; ITALY; LIVER NEOPLASMS; MALE; MIDDLE AGED; SMOKING;

EID: 33646252278     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0702     Document Type: Article

References (48)

1. El Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 2004;127 Suppl 1:S27-34.
2. Shibuya K, Yano E. Regression analysis of trends in mortality from hepatocellular carcinoma in Japan, 1972-2001. Int J Epidemiol 2005;34: 397-402.
3. La Vecchia C, Lucchini F, Franceschi S, Negri E, Levi F. Trends in mortality from primary liver cancer in Europe. Eur J Cancer 2000;36:909-15.
4. Tanaka Y, Hanada K, Mizokami M, et al. Inaugural Article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 2002;99: 15584-9.
5. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma, Hepatology 1997;26 Suppl 1:S34-8.
6. La Vecchia C, Negri E, Decarli A, D'Avanzo B, Franceschi S. Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 1988;4:872-6.
7. Kuper H, Tzonou A, Kaklamani E, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000;85:498-502.
8. Wang LY, You SL, Lu SN, et al. Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 2003;14:241-50.
9. Yuan JM, Govindarajan S, Arakawa K, Yu MC. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004;101:1009-17.
10. Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R. Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs 17,000 cirrhosis deaths. Int J Cancer 2003;107:106-12.
11. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 83: Tobacco Smoke and Involuntary Smoking. Lyon: IARC Press; 2004.
12. La Vecchia C, Pagano R, Negri E, Decarli A. Determinants of alcohol consumption in Italy. Int J Epidemiol 1987;16:295-6.
13. Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994;20:1442-9.
14. Montella M, Crispo A, Grimaldi M, et al. Prevalence of hepatitis C virus infection in different population groups in southern Italy. Infection 2005; 33:9-12.
15. Talamini R, Montella M, Crovatto M, et al. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer 2004;110:380-5.
16. Dal Maso L, Talamini R, Montella M, Crovatto M, Franceschi S. Hepatitis B and C viruses and Hodgkin lymphoma: a case-control study from Northern and Southern Italy. Haematologica 2004;89:ELT17.
17. Ferraroni M, Decarli A, Franceschi S, et al. Validity and reproducibility of alcohol consumption in Italy. Int J Epidemiol 1996;25:775-82.
18. D'Avanzo B, La Vecchia C, Talamini R, Franceschi S. Anthropometric measures and risk of cancers of the upper digestive and respiratory tract. Nutr Cancer 1996;26:219-27.
19. Colin C, Lanoir D, Touzet S, Meyaud-Kraemer L, Bailly F, Trépo C. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat 2001;8:87-95.
20. Chemin I, Zoulim F, Merle P, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 2001;34: 447-54.
21. Pichoud C, Seigneres B, Wang Z, Trépo C, Zoulim F. Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. Hepatology 1999;29:230-7.
22. Li JS, Vitvitski L, Tong SP, Trépo C. Identification of the third major genotype of hepatitis C virus in France. Biochem Biophys Res Commun 1994;199:1474-81.
23. Li JS, Tong SP, Vitvitski L, Trépo C. Single-step nested polymerase chain reaction for detection of different genotypes of hepatitis C virus. J Med Virol 1995;45:151-5.
24. Breslow NE, Day NE. Statistical Methods in Cancer Research Vol. I: The analysis of case-controls studies. IARC scientific publication no 32. Lyon: International Agency for Research on Cancer; 1980.
25. Mezzetti M, Ferraroni M, Decarli A, La Vecchia C, Benichou J. Software for attributable risk and confidence interval estimation in case-control studies. Comput Biomed Res 1996;29:63-75.
26. Stanta G, Croce LS, Bonin S, Tisminetzky SG, Baralle FE, Tiribelli C. Cohort effect of HCV infection in liver cirrhosis assessed by a 25 year study. J Clin Virol 2000;17:51-6.
27. Deuffic S, Buffat L, Poynard T, Valleron AJ. Modeling the hepatitis C virus epidemic in France. Hepatology 1999;29:1596-601.
28. Law MG, Dore GJ, Bath N, et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int J Epidemiol 2003;32:717-24.
29. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003;9:331-8.
30. Shi J, Zhu L, Liu S, Xie WF. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br J Cancer 2005;92:607-12.
31. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 1998;75:347-54.
32. Montella M, Crispo A, Izzo F, et al. HCV and hepatocellular carcinoma: A case-control study in an area of hyperendemicity. Int J Mol Med 2000; 6:571-4.
33. Kirk GD, Lesi OA, Mendy M, et al. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology 2004;39:211-9.
34. Hassan MM, Frome A, Patt YZ, El Serag HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol 2002; 35:266-9.
35. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004;127:1372-80.
36. Di Bisceglie AM, Lyra AC, Schwartz M, et al. Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 2003;98:2060-3.
37. Bréchot C, Jaffredo F, Lagorce D, et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol 1998;29:173-83.
38. Hatzakis A, Katsoulidou A, Kaklamani E, et al. Hepatitis C virus 1b is the dominant genotype in HCV-related carcinogenesis: a case-control study. Int J Cancer 1996;68:51-3.
39. Raimondo G, Pollicino T, Squadrito G. What is the clinical impact of occult hepatitis B virus infection? Lancet 2005;365:638-40.
40. Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst 2005;97:265-72.
41. Kuper HE, Tzonou A, Kaklamani E, et al. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays. Cancer Causes Control 2000;11:171-5.
42. IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 59: Hepatitis Viruses. Lyon: IARC; 1994.
43. La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 1998;7:315-20.
44. Adami HO, Hsing AW, McLaughlin JK, et al. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer 1992;51:898-902.
45. Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002;155:323-31.
46. Guadagnino V, Stroffolini T, Rapicetta M, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997;26:1006-11.
47. Montella M, Crispo A, Serraino D, Rezza G, Franceschi S. Is the spread of HCV in Southern Italy attributable to iatrogenic transmission through unsterile injections? Eur J Cancer Prev 2003;12:85-6.
48. Omata M. Regression of liver fibrosis in patients treated by interferon. Intern Med 2004;43:887-8.